Autolus Reports FDA Approval and NCCN Inclusion of AUCATZYL, Sets Milestones for Pipeline Growth
Press Release: Autolus Therapeutics Provides Business Updates and 2025 Overview
Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?
European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading
Express News | Reported Earlier, Autolus Therapeutics Revealed New Data Supporting Obe-cel's Clinical And Economic Benefits At ASH 2024
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}